| # | Country | Total Patents | |
|---|---|---|---|
| #1 | France | 5 | |
| #2 | Canada | 3 | |
| #3 | Australia | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Measuring microorganism processes | |
| #5 | Microorganisms | |
| #6 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Colin Sylvie | 14 |
| #2 | Schneider Christophe | 13 |
| #3 | Al-Mahmood Salman | 10 |
| #4 | Al Mahmood Salman | 5 |
| #5 | Grommidh Charles | 1 |
| Publication | Filing date | Title |
|---|---|---|
| FR2843753A1 | Antisense nucleic molecule useful as inhibitor of angiogenesis in the treatment of angiogenic disorders, e.g., rheumatoid arthritis, atherosclerosis and endometriosis | |
| WO03074073A2 | Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof | |
| FR2836686A1 | Compositions containing nucleic acid or polypeptide differentially expressed in angiogenesis are useful to diagnose, prognose and treat angiogenic disorders including tumor vascularization and heart disease |